Citation: Carole Guillevin, Rémy Guillevin, Alain Miranville, Angélique Perrillat-Mercerot. Analysis of a mathematical model for brain lactate kinetics[J]. Mathematical Biosciences and Engineering, 2018, 15(5): 1225-1242. doi: 10.3934/mbe.2018056
[1] | Sandesh Athni Hiremath, Christina Surulescu, Somayeh Jamali, Samantha Ames, Joachim W. Deitmer, Holger M. Becker . Modeling of pH regulation in tumor cells: Direct interaction between proton-coupled lactate transporters and cancer-associated carbonicanhydrase. Mathematical Biosciences and Engineering, 2019, 16(1): 320-337. doi: 10.3934/mbe.2019016 |
[2] | Allen L. Nazareno, Raymond Paul L. Eclarin, Eduardo R. Mendoza, Angelyn R. Lao . Linear conjugacy of chemical kinetic systems. Mathematical Biosciences and Engineering, 2019, 16(6): 8322-8355. doi: 10.3934/mbe.2019421 |
[3] | OPhir Nave, Shlomo Hareli, Miriam Elbaz, Itzhak Hayim Iluz, Svetlana Bunimovich-Mendrazitsky . BCG and IL − 2 model for bladder cancer treatment with fast and slow dynamics based on SPVF method—stability analysis. Mathematical Biosciences and Engineering, 2019, 16(5): 5346-5379. doi: 10.3934/mbe.2019267 |
[4] | Amer Hassan Albargi, Miled El Hajji . Mathematical analysis of a two-tiered microbial food-web model for the anaerobic digestion process. Mathematical Biosciences and Engineering, 2023, 20(4): 6591-6611. doi: 10.3934/mbe.2023283 |
[5] | Blessing O. Emerenini, Stefanie Sonner, Hermann J. Eberl . Mathematical analysis of a quorum sensing induced biofilm dispersal model and numerical simulation of hollowing effects. Mathematical Biosciences and Engineering, 2017, 14(3): 625-653. doi: 10.3934/mbe.2017036 |
[6] | Urszula Foryś, Jan Poleszczuk . A delay-differential equation model of HIV related cancer--immune system dynamics. Mathematical Biosciences and Engineering, 2011, 8(2): 627-641. doi: 10.3934/mbe.2011.8.627 |
[7] | Swadesh Pal, Malay Banerjee, Vitaly Volpert . Spatio-temporal Bazykin’s model with space-time nonlocality. Mathematical Biosciences and Engineering, 2020, 17(5): 4801-4824. doi: 10.3934/mbe.2020262 |
[8] | Awatif Jahman Alqarni, Azmin Sham Rambely, Sana Abdulkream Alharbi, Ishak Hashim . Dynamic behavior and stabilization of brain cell reconstitution after stroke under the proliferation and differentiation processes for stem cells. Mathematical Biosciences and Engineering, 2021, 18(5): 6288-6304. doi: 10.3934/mbe.2021314 |
[9] | Boumediene Benyahia, Tewfik Sari . Effect of a new variable integration on steady states of a two-step Anaerobic Digestion Model. Mathematical Biosciences and Engineering, 2020, 17(5): 5504-5533. doi: 10.3934/mbe.2020296 |
[10] | Pei Yu, Xiangyu Wang . Analysis on recurrence behavior in oscillating networks of biologically relevant organic reactions. Mathematical Biosciences and Engineering, 2019, 16(5): 5263-5286. doi: 10.3934/mbe.2019263 |
The brain is an organ with high energy needs. While it represents only 2% of the body weight it grabs at least 20% of its total energy needs [9]. The consumed energy can come from many forms such as glutamate, glucose, oxygen and also lactate [3]. Energy is necessary to support neural activity. Gliomas are the most frequent primary brain tumors (more than 50% of brain cancer cases according to the ICM institute). Like other cancers, they lead to alterations of cells' energy management. In particular, lactate creation, consumption, import and export of a glioma cell seem to play a key role in the cancer development [5]-[11]. Today, neuroimaging techniques allow an indirect and noninvasive measure of cerebral activity. It also enables measurement of various metabolic concentrations such as lactate and measurement of important biological parameters such as the relative cerebral blood volume (allowing relative cerebral blood flow calculations). But because energy management in healthy and tumoral cells and glioma growth can be difficult to observe and explain experimentally, we propose to use mathematical modeling to help to describe and understand cells energy changes.
To the best of our knowledge, only a few mathematical models have been proposed to study lactate fluxes in the brain and the interconnections with energy, see [3] for example. We aim herein at analyzing a model first described in [2].
Our paper is organized as follows. We first present the mathematical model proposed to describe the mechanisms of interest. We then investigate its well-posedness and derive bounds on the solutions. Indeed, such an analysis is necessary to justify how a mathematical model is well-adapted to a biological problem. We also analyze the limit model and study its steady state. Bounds on the solutions are important as they are related with the viability domain of the cell. Furthermore, as mentioned in [8], a therapeutic perspective is to have the steady state outside the viability domain where cell necrosis occurs. Additionnally, we present numerical simulations with different values of the small parameter
The present model is reduced in order to follow in a simpler way lacate kinetics between a cell and the capillary network in its neighborhood. It is built in vivo which means that we have to consider loss and input terms for both intracellular and capillary lactate concentrations. We denote by
First, there is a lactate cotransport through the brain blood. It is taken into account by a simplified version of an equation for carrier-mediated symport. This nonlinear term depends on the maximum transport rate between the blood and the cell
Then a cell can equally produce and consume lactate, but also export surplus lactate to neighboring cells. We denote by
Next there is a blood flow contribution to capillary lactate depending on both arterial and venous lactates. We denote by
Finally, we have the following ODE's, for
u′ε(t)=J(t,uε(t))−T(uε(t)k+uε(t)−vε(t)k′+vε(t)), | (2.1) |
εv′ε(t)=F(t)(L−vε(t))+T(uε(t)k+uε(t)−vε(t)k′+vε(t)). | (2.2) |
The initial condition is given by :
(uε(0);vε(0))=(ˉu0;ˉv0)∈R+×R+. |
The model is biologically described in [2], to which we refer the interested readers for a better understanding of this process.
Well-posedness. Recall that an ODE system
x⩾0,xk=0⇒fk(t,x)⩾0 |
is verified for all
Since we have for nonnegative
|u1k+u1−u2k+u2|=k|u2−u1|(k+u1)(k+u2)⩽|u2−u1|k, |
then we can rewrite (2.1)-(2.2), setting
X(t):=(uε(t);vε(t)), |
to have
X′(t)=H(t,X(t)), X(0)=X0, |
where
Bounds on the solution. By means of (2.2), we have
v′ε(t)⩽−F1vε(t)ε+F2Lε+Tε, |
which implies, using Gronwall's lemma, that
vε(t)⩽exp(−F1tε)ˉv0+∫t0exp(−F1(t−s)ε)T+F2Lεds, |
or equivalently,
vε(t)⩽exp(−F1tε)ˉv0+T+F2LF1(1−exp(−F1tε)). |
One can see, using the above formula, that we have
vε(t)⩽max(ˉv0,T+F2LF1):=Bv. |
Theorem 3.1. We can exhibit a sufficient, but not necessary, condition to ensure a bound on
∀(t,x)∈R2, J(t,x)⩽BJ |
and :
BJ<T(1−Bvk′+Bv)⇔BJ(k′+Bv)<Tk′.(C2.1) |
In that case, we have, setting
uε(t)⩽max(kz1−z,ˉu0):=Bu. | (3.1) |
Remark 1. Condition
Proof. Equation (2.1) gives
u′ε(t)⩽BJ+TBvBv+k′−Tuε(t)k+uε(t). |
We set
1−z=(k′+Bv)T(k′+Bv)T−Bv(T+BJ)+k′BJ(k′+Bv)T=k′T−BJ(k′+Bv)(k′+Bv)T>0. |
Let
uε(t)>kz1−z. |
Then,
uε(t)(1−Bvk′+Bv−BJT)>k(Bvk′+Bv+BJT), |
which yields
BJ+TBvBv+k′−Tuε(t)k+uε(t)<0, |
hence
u′ε(t)<0. |
We finally deduce that
uε(t)⩽max(kz1−z,ˉu0). |
Remark 2. This condition on an upper bound on
Jtest(s,x)=GJ⏟creation−LJ⏟ consumption+CJεJ+x⏟import, |
for positive constants
We have already proved that
v′ε(t)⩾−F2vε(t)ε+F1Lε−TεBvk′+Bv. |
Then, if
vε(t)⩽F1L−TBvk′+BvF2, |
we have
vε(t)⩾min(ˉv0,F1L−TBvk′+BvF2). |
If
vε(t)⩾min(ˉv0,max(F1L−TBvk′+BvF2,0)):=Mv. | (3.2) |
Similarly,
u′ε(t)⩾T(Mvk′+Mv−uεk+uε). |
Then
uε(t)⩾min(ˉu0,Mvkk′):=Mu. | (3.3) |
Remark 3. The upper bound
vε(t)⩽max(supˉv0ε>0,T+F2LF1). |
The lower bounds
Stability of the equilibrium. For constant
ul:=k(JT+vlk′+vl)1−(JT+vlk′+vl), | (3.4) |
vl:=L+JF. | (3.5) |
It has also been proven that this unique stationary point is a node, hence a locally stable equilibrium. However, this equilibrium does not always exist. For existence, the parameters need to satisfy :
JT+LF+JF(k′+L)+J<1⇔J2+JF(L+k′)−TFk′<0. | (3.6) |
Remark 4. We have already shown that
J2+JF(L+k′)−TFk′>T2+TF(L+k′)−TFk′=T(T+FL)>0. |
Therefore, the contraposition leads to:
J2+JF(L+k′)−TFk′⩽0 implies J⩽T. |
We fix all the parameters but
ΔJ=F2(L+k′)2+4TFk′>0 |
and there is an equilibrium only when
Jb:=12(−F(L+k′)−√ΔJ),Jh:=12(−F(L+k′)+√ΔJ). |
Knowing that
1.
2.
A therapeutic perspective is to have the steady state outside the viability domain [8]. Therefore playing on cell lactate intake could be worth exploring: a large
We now study the limit system for
u′0(t)=J−T(u0(t)k+u0(t)−v0(t)k′+v0(t)), | (4.1) |
0=F(L−v0(t))+T(u0(t)k+u0(t)−v0(t)k′+v0(t)), | (4.2) |
together with the initial condition :
u0(0)=ˉu0∈R+. |
We first give some preliminary results and then establish bounds on the solutions and study the well-posedness of the system. We finally compare the original system (with
Preliminaries. The function
We define the function
φc{]−c,+∞[→]−∞,T[s↦Tsc+s. |
It is easy to see that
φ−1c{[0,T[→[0,+∞[z↦czT−z. |
Furthermore, we introduce the function
ψc{]−c,+∞[→R s↦Fs+φc(s), |
where
ψ′c(s)=F+Tc(c+s)2. |
Employing (4.2), we have :
ψk′(v0(t))=FL+φk(u0(t)). |
We rewrite (4.1)-(4.2) as :
v0(t)=ψ−1k′(FL+φk(u0(t))):=Ψ(u0(t)), | (4.3) |
u′0(t)=J−T(u0(t)k+u0(t)−Ψ(u0(t))k′+Ψ(u0(t))):=G(t,u0(t)), | (4.4) |
and set, for
Ψ−1(y)=φ−1k(ψk′(y)−FL). |
A priori bounds on the solutions. Thanks to (4.4), we have :
G(t,0)=J+Tψ−1k′(FL)k′+ψ−1k′(FL)⩾J, |
and the system is quasipositive : for an initial condition
Using (4.2), we find an upper bound on
v0(t)⩽L+TF:=Bv,0. | (4.5) |
We can also obtain an upper bound on
We now rewrite (4.2) as :
v0(t)2+v0(t)(k′−L+TF−z)−k′(L+z)=0, |
where
Noting that
v0(t)=12(z+L−TF−k′+√(TF+k′−L−z)2+4k′(L+z)). | (4.6) |
Well-posedness. Equation (4.4) gives :
u′0(t)=J−T(u0(t)k+u0(t)−Ψ(u0(t))k′+Ψ(u0(t))):=G(t,u0(t)). |
Lemma 1. The function
|Ψ(u1)−Ψ(u2)|⩽KL|u1−u2|. |
Proof. Let
Ψ′(u)=1(Ψ−1)′(Ψ(u)) |
and :
|(Ψ−1)′(Ψ(u))|=|(φ−1k)′(ψk′(Ψ(u))−FL)ψk′(Ψ(u)))|=|Tk(T−ψk′(Ψ(u))+FL)2(F+Tk(k+Ψ(u))2)|=|Tk(Tk+F(k+Ψ(u))2)(T+φk(u))2(k+Ψ(u))2|. |
It follows from the above that
0=F(L−v)+T(uk+u−vk′+v)⇒v⩽FL+T=Bv,0,v⩾0. |
Therefore,
|Ψ′(u)|=1|(Ψ−1)′(Ψ(u))|=|(T+φk(u))2(k+Ψ(u))2Tk(Tk+F(k+Ψ(u))2)|⩽(T+Tuk+u)2(k+Ψ(u))2⩽4T2(k+Bv,0)2:=KL. |
Consequently,
Stability of the equilibrium. As proved in [3], (4.1)-(4.2) can have at most one equilibrium given under the above parameters condition. The Jacobian of the system at this point gives the eigenvalue :
λ:=−Tk(k+ul)2<0. |
Therefore,
Tulk+ul=Tkzl1−zl1−zlk=Tzl=TJT+Tvlk′+vl=F(JF+L−L)+Tvlk′+vl=F(vl−L)+Tvlk′+vl. |
Thus :
Fvl+Tvlk′+vl=FL+Tulk+ul⇔vl=Ψ(ul), |
and the stationnary point
Comparison between the original and the limit systems. We wish to bound the difference between
uε(0)=u0(0)=ˉu0. |
We set
u′(t)=T(k′v(t)(vε(t)+k′)(v0(t)+k′)−ku(t)(uε(t)+k)(u0(t)+k)), | (4.7) |
εv′(t)=−Fv(t)+T(ku(t)(uε(t)+k)(u0(t)+k)−k′v(t)(vε(t)+k′)(v0(t)+k′))−εv′0(t). | (4.8) |
It follows from the above that,
u′0(t)=J−T(u0(t)k+u0(t)−v0(t)k′+v0(t))∈[J−T,J+T],v0(t)⩽Bv,0, |
Therefore, differentiating (4.2), we find :
Fv′0(t)=T(ku′0(t)(k+u0(t))2−k′v′0(t)(k′+v0(t))2)⇒v′0(t)(F+k′T(k′+v0(t))2)=Tku′0(t)(k+u0(t))2, |
hence
|v′0(t)|⩽kT(J+T)(F+k′T(k′+Bv,0)2):=γ. |
Next, multiplying
12ddt(u2(t))⩽Tk′|u(t)||v(t)|, | (4.9) |
ε12ddt(v2(t))+Fv2(t)⩽Tk|u(t)||v(t)|+ε|v(t)|γ. | (4.10) |
Noting that
Tk|u(t)||v(t)|+ε|v(t)|γ=(Tk|u(t)|2√F)(√F2|v(t)|)+(|v(t)|√F2)(2√Fεγ)⩽F2v2(t)+4T2Fk2u2(t)+4γ2Fε2 |
and
Tk′|u(t)||v(t)|=(Tk′|u(t)|√2√F)(√F√2|v(t)|)⩽F2v2(t)+2T2Fk′2u2(t), |
summing (4.9) and (4.10) thus yields,
ddt(u2(t)+εv2(t))⩽(8T2Fk2+4T2Fk′2)(u2(t)+εv2(t))+8γ2Fε2. |
Noting finally that :
u2(0)=0 and u2(0)+εv2(0)=ε(ˉv0−Ψ(ˉu0))2, |
Gronwall's lemma gives,
u2(t)+εv2(t)⩽exp(T2tF(8k2+4k′2))(ε(ˉv0−Ψ(ˉu0))2+k2(J+T)2(F+k′T(k′+L+TF)2)22ε2(2k2+1k′2))−k2(J+T)2(F+k′T(k′+L+TF)2)22ε2(2k2+1k′2). |
Remark 5. In the particular case
u2(t)+εv2(t)⩽(exp(T2tmF(8k2+4k′2))−1)2γ2ε2T2(2k2+1k′2) |
which yields that, on the finite time interval
|u(t)|⩽Ctmε,|v(t)|⩽Ctm√ε. | (4.11) |
Remark 6. Setting
In this section, we first present several numerical simulations with relevant values of our parameters. We also compare the numerical simulations with different values of
Numerical illustration with nonconstant
J{R+→R+ x↦GJ−Lj+Cjx+εj, |
containing a creation term, a consumption term and an import term. This function
F{R+→R+t↦{F0(1+αf)if∃N∈N/(N−1)tf+ti<t<Ntf,F0ifnot |
The parameters for these two functions are given in Table 1.
Parameter | Value | Unit |
| 0.012 | s |
| 0.5 | |
| 50 | |
| 100 | |
| 5.7*10 | |
| 0.001 | |
| 0.002 | |
| 0.001 | |
We also consider the parameters given in [2] and [8]. In that case,
Parameter | Value | Unit |
| 0.01 | mM.s |
| 3.5 | mM |
| 3.5 | mM |
| 0.3 | mM |
| 0.001 | s |
The solutions
Numerical simulations with different values of
Parameter | Value | Unit |
| 0.01 | mM.s |
| 3.5 | mM |
| 3.5 | mM |
| 0.3 | mM |
| 0.0057 | mM.s |
| 0.0272 | s |
| 0.1 | s |
Note that, in that case, we have shown the existence of an upper bound on
Using the parameters values given in Table 3, we perform numerical simulations with various values of
While the intracellular lactate trajectories seem not to differ a lot, the capillary lactate trajectories show different initial dynamics. The smaller
Remark 7. An approach based on singular perturbation theory has been made on this model by Lahutte-Auboin et al. [7,8]. There, the authors give a geometrical explanation for the initial lactate dip and prove the existence of a periodic solution of the fast-slow system under a repetitive sequence of identical stimuli. In addition, our approach gives an estimate on the rate of convergence with respect to the parameters, which is usually not the case with singular perturbation theory.
Using the parameters given in Table 3, we now test different values for
There is a limit value of
Jlim=0.00851 mM.s−1. |
There are two types of dynamics : those with
Experimental data. In this section we compare typical results obtained by using the model (with constant
For each five patients we have four lactate concentration measures (only three for patient 1) separated from each other by more than
We are unable to distinguish between capillary lactate and intracellular lactate using imaging data. Therefore lactate concentration measures are the sum of the capillary lactate and intracellular lactate concentrations.
Because lactate concentrations variations are intrinsic and depend on lactate exchanges, we assume that it is relevant to adjust the initial values (
Parameter | Value | Unit |
| 0.1 | mM.d |
| 3.5 | mM |
| 3.5 | mM |
| 0.3 | mM |
| 0.0272 | d |
| 0.1 | d |
The results are given in Figure 7. Fitted values of
Patient | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Our model (with constant
In this study we analyze a model for lactate kinetics first given in [2]. This model is a first step in view of a better understanding of lactate dynamics in the brain. Lactate has a key role in neuroenergetics. Therefore studying its dynamics in the brain is necessary to better understand the energetic breakdown which is observed, for example in tumors. This model is known to give good results when fitted with experimental data [2], [8]. However, to the best of our knowledge, no mathematical analysis has been made to show the existence and uniqueness of the solution and conditions for bounds on the solution, but also comparisons between the original and limit systems.
In this paper, we study the original and limit systems and obtain existence, uniqueness and bounds on the solutions for the two systems. We also give a condition on
When confronted with imaging data from NMR spectroscopy and perfusion, the model provides good results. Because there are large time variations, we cannot ensure that all the parameters remain constant in time. Therefore constant parameters are not good for explaining hard changes on the lactate concentration dynamics such as shifting from a decreasing concentration to an increasing one. Despite this, they can explain what happens after a lactate spike.
Differences in lactate dynamics suggest that there are several glioma profiles with different typical kinetics. This could indicate that non-agressive low grade gliomas show an increasing lactate concentration and then move to more agressive form (WHO Ⅱ+ to WHO Ⅲ+). At this stage the glioma will exhibit angiogenesis, modified proteins and altered transporters, which leads to fluctuating lactate kinetics [6]. This point should be considered as a critical one because of its therapeutical management consequences. Yet the patient should be referred to more agressive therapeutics such as radiotherapy or chemotherapy. Also the imaging control frequency should be restrained as well.
As already mentioned in [10], an initial dip exists in the brain lactate dynamics. This dip could be mathematically explained by the different initial values of the capillary lactate concentration between the original and limit systems. Therefore the dip can be biologically explained by compartment volume modifications.
It cannot be excluded that
Indeed one perspective is to build more complex and suitable models for brain metabolism. Adding oxygen and glucose dynamics to this model can be the next step in view of a more accurate description of energy dynamics in the brain. It could also be interesting to build a model with different cell types (such as astrocyte and neuron), for a better understanding of the brain fuel substrate fluxes.
The authors wish to thank an anonymous referee for her/his careful reading of the paper and helpful comments.
[1] | [ A. Aubert,R. Costalat, Interaction between astrocytes and neurons studied using a mathematical model of compartmentalized energy metabolism, Journal of Cerebral Blood Flow & Metabolism, 25 (2005): 1476-1490. |
[2] | [ A. Aubert,R. Costalat,P. Magistretti,J. Pierre,L. Pellerin, Brain lactate kinetics: modeling evidence for neuronal lactate uptake upon activation, Proceedings of the National Academy of Sciences of the United States of America, 102 (2005): 16448-16453. |
[3] | [ M. Cloutier,F. B. Bolger,J. P. Lowry,P. Wellstead, An integrative dynamic model of brain energy metabolism using in vivo neurochemical measurements, Journal of Computational Neuroscience, 27 (2009): 391-414. |
[4] | [ R. Costalat,J.-P. Françoise,C. Menuel,M. Lahutte,J.-N. Vallée,G. De Marco,J. Chiras,R. Guillevin, Mathematical modeling of metabolism and hemodynamics, Acta Biotheoretica, 60 (2012): 99-107. |
[5] | [ C. E. Griguer,C. R. Oliva,G. Y. Gillespie, Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines, Journal of Neuro-oncology, 74 (2005): 123-133. |
[6] | [ R. Guillevin,C. Menuel,J.-N. Vallée,J.-P. Françoise,L. Capelle,C. Habas,G. De Marco,J. Chiras,R. Costalat, Mathematical modeling of energy metabolism and hemodynamics of WHO grade Ⅱ gliomas using in vivo MR data, Comptes rendus biologies, 334 (2011): 31-38. |
[7] | [ M. Lahutte-Auboin, R. Costalat, J.-P. Françoise, R. Guillevin, Dip and Buffering in a fast-slow system associated to Brain Lactacte Kinetics, preprint, arXiv: 1308.0486. |
[8] | [ M. Lahutte-Auboin,R. Guillevin,J.-P. Françoise,J.-N. Vallée,R. Costalat, On a minimal model for hemodynamics and metabolism of lactate : application to low grade glioma and therapeutic strategies, Acta Biotheoretica, 61 (2013): 79-89. |
[9] | [ P. J. Magistretti,I. Allaman, A cellular perspective on brain energy metabolism and functional imaging, Neuron, 86 (2015): 883-901. |
[10] | [ S. Mangia,G. Garreffa,M. Bianciardi,F. Giove,F. Di Salle,B. Maraviglia, The aerobic brain: Lactate decrease at the onset of neural activity, Neuroscience, 118 (2003): 7-10. |
[11] | [ J. R. Mangiardi,P. Yodice, Metabolism of the malignant astrocytoma, Neurosurgery, 26 (1990): 1-19. |
1. | A. Perrillat-Mercerot, C. Guillevin, A. Miranville, R. Guillevin, Using mathematics in MRI data management for glioma assesment, 2019, 01509861, 10.1016/j.neurad.2019.11.004 | |
2. | Angélique Perrillat-Mercerot, Alain Miranville, Abramo Agosti, Elisabetta Rocca, Pasquale Ciarletta, Rémy Guillevin, Partial differential model of lactate neuro-energetics: analytic results and numerical simulations, 2021, 1477-8599, 10.1093/imammb/dqaa016 | |
3. | Angélique Perrillat-Mercerot, Nicolas Bourmeyster, Carole Guillevin, Alain Miranville, Rémy Guillevin, Mathematical Modeling of Substrates Fluxes and Tumor Growth in the Brain, 2019, 67, 0001-5342, 149, 10.1007/s10441-019-09343-1 | |
4. | Remy Guillevin, 2018, Chapter 5, 978-3-319-78924-8, 93, 10.1007/978-3-319-78926-2_5 | |
5. | Lu Li, Alain Miranville, Rémy Guillevin, Cahn–Hilliard Models for Glial Cells, 2020, 0095-4616, 10.1007/s00245-020-09696-x | |
6. | Monica Conti, Stefania Gatti, Alain Miranville, Mathematical analysis of a model for proliferative-to-invasive transition of hypoxic glioma cells, 2019, 189, 0362546X, 111572, 10.1016/j.na.2019.111572 | |
7. | Laurence Cherfils, Stefania Gatti, Alain Miranville, Rémy Guillevin, Analysis of a model for tumor growth and lactate exchanges in a glioma, 2020, 0, 1937-1179, 0, 10.3934/dcdss.2020457 | |
8. | Hussein Raad, Laurence Cherfils, Cyrille Allery, Rémy Guillevin, Optimal control of a model for brain lactate kinetics, 2023, 18758576, 1, 10.3233/ASY-221823 | |
9. | Laurence Cherfils, Stefania Gatti, Carole Guillevin, Alain Miranville, Rémy Guillevin, On a tumor growth model with brain lactate kinetics, 2022, 39, 1477-8599, 382, 10.1093/imammb/dqac010 | |
10. | Hawraa Alsayed, Hussein Fakih, Alain Miranville, Ali Wehbe, On an Optimal Control Problem Describing Lactate Transport Inhibition, 2023, 0022-3239, 10.1007/s10957-023-02271-8 | |
11. | Hussein Raad, Cyrille Allery, Laurence Cherfils, Carole Guillevin, Alain Miranville, Thomas Sookiew, Luc Pellerin, Rémy Guillevin, Simulation of tumor density evolution upon chemotherapy alone or combined with a treatment to reduce lactate levels, 2024, 9, 2473-6988, 5250, 10.3934/math.2024254 | |
12. | Nour Ali, Hussein Fakih, Ali Wehbe, On a singular mathematical model for brain lactate kinetics, 2024, 0170-4214, 10.1002/mma.9898 | |
13. | Laurence Cherfils, Stefania Gatti, Alain Miranville, Hussein Raad, Rémy Guillevin, Optimal control of therapies on a tumor growth model with brain lactate kinetics, 2024, 0, 1937-1632, 0, 10.3934/dcdss.2024032 |
Parameter | Value | Unit |
| 0.012 | s |
| 0.5 | |
| 50 | |
| 100 | |
| 5.7*10 | |
| 0.001 | |
| 0.002 | |
| 0.001 | |
Parameter | Value | Unit |
| 0.01 | mM.s |
| 3.5 | mM |
| 3.5 | mM |
| 0.3 | mM |
| 0.001 | s |
Parameter | Value | Unit |
| 0.01 | mM.s |
| 3.5 | mM |
| 3.5 | mM |
| 0.3 | mM |
| 0.0057 | mM.s |
| 0.0272 | s |
| 0.1 | s |
Parameter | Value | Unit |
| 0.1 | mM.d |
| 3.5 | mM |
| 3.5 | mM |
| 0.3 | mM |
| 0.0272 | d |
| 0.1 | d |
Patient | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Parameter | Value | Unit |
| 0.012 | s |
| 0.5 | |
| 50 | |
| 100 | |
| 5.7*10 | |
| 0.001 | |
| 0.002 | |
| 0.001 | |
Parameter | Value | Unit |
| 0.01 | mM.s |
| 3.5 | mM |
| 3.5 | mM |
| 0.3 | mM |
| 0.001 | s |
Parameter | Value | Unit |
| 0.01 | mM.s |
| 3.5 | mM |
| 3.5 | mM |
| 0.3 | mM |
| 0.0057 | mM.s |
| 0.0272 | s |
| 0.1 | s |
Parameter | Value | Unit |
| 0.1 | mM.d |
| 3.5 | mM |
| 3.5 | mM |
| 0.3 | mM |
| 0.0272 | d |
| 0.1 | d |
Patient | | | |
| | | |
| | | |
| | | |
| | | |
| | | |